ViCentra, the Utrecht-based medtech company behind the Kaleido insulin patch pump, has raised $85M (~€72M) in Series D funding to scale manufacturing, expand across Europe, and prepare for entry into the US.
ViCentra, the Utrecht-based medtech company behind the Kaleido insulin patch pump, has raised $85M (~€72M) in Series D funding to scale manufacturing, expand across Europe, and prepare for entry into the US.
Molecular You, a Vancouver-based healthtech startup, has raised $6.9 million CAD ($5M USD) in Series A funding to accelerate the rollout of its predictive blood testing platform across North America.
Phasecraft, a London-based quantum computing startup, has raised $34 million (~€31.5M) in Series B funding to accelerate development of algorithms that make noisy quantum computers useful for real-world problems.
Arivin Therapeutics, a Finnish-Dutch biotech spin-off from Aalto University and the University of Helsinki, has raised €3 million in seed funding to advance therapies for drug-resistant bacterial infections.
Tangany, a Munich-based BaFin-regulated digital asset custodian, has secured €10 million in Series A funding to expand its role in Europe’s regulated crypto infrastructure.
Intella, the MENA-based leader in Arabic speech intelligence, has raised $12.5 million in an oversubscribed Series A round led by Prosus Ventures, with participation from 500 Global, Wa’ed Ventures, Hala Ventures, Idrisi Ventures, and HearstLab.
Allasso, a Geneva-based fintech company, has raised $3M (~€2.5M) in funding to scale its next-generation analytics and risk management tools for traders and financial institutions.
Netomnia, the UK’s second-largest alternative network provider, has raised £300M (~€346M) in junior debt funding to expand its nationwide fibre rollout.
Artificial Societies, a London-based AI simulation platform, has raised $5.3 million (~€4.5M) across pre-seed and seed rounds to expand its technology that lets companies test ideas with digital personas before taking them to market.
Taaleri Bioindustry, the Helsinki-based investment arm of Taaleri Group, has invested €10 million in Finnish Food Factory, a contract manufacturer specialising in plant-based dairy alternatives.
